A class action lawsuit has been filed against Varonis Systems for allegedly making materially false statements about its business prospects. The company failed to disclose that it lacked the ability to maintain its ARR growth trajectory without high quarterly conversion rates. On October 28, 2025, Varonis reported a 63.9% decline in term license subscription revenues year-over-year, causing its stock to plummet 48.7%. Investors who purchased shares between February 4 and October 28, 2025 have until March 9, 2026 to apply as lead plaintiffs.

A class action lawsuit has been filed against Varonis Systems, Inc. alleging that the company made materially false statements and failed to disclose material facts regarding its ability to convert customers to its SaaS offering, resulting in artificially inflated stock prices during the class period of February 4, 2025 to October 28, 2025. Investors who suffered losses have until March 9, 2026 to request lead plaintiff status.

Holzer & Holzer, LLC announces March 9, 2026 deadline for investors to seek lead plaintiff status in shareholder class action lawsuits against Ardent Health, Inc. and Varonis Systems, Inc. Ardent Health faces allegations of false statements regarding accounts receivable collectability (July 2024-November 2025), while Varonis faces allegations regarding misstatements about customer conversion ability and ARR growth potential (February-October 2025).

Varonis Systems faces a securities class action lawsuit alleging executives concealed renewal softness in its Federal vertical and legacy on-premises business while misrepresenting the success of its SaaS transition. The company's October 28, 2025 disclosure of conversion failures and slashed guidance triggered a 48% single-day stock crash, erasing $3.8 billion in market value. The lead plaintiff deadline is March 9, 2026.

Pomerantz Law Firm has filed a class action lawsuit against Varonis Systems, Inc., alleging securities fraud and unlawful business practices. The lawsuit stems from Varonis's October 28, 2025 earnings report, which revealed a 63.9% decline in term license subscription revenues and reduced full-year ARR guidance due to underperformance in its on-premises subscription business. The stock price fell 48.67% following the announcement. The deadline to join the class action as Lead Plaintiff is March 9, 2026.

Pomerantz Law Firm has filed class action lawsuits against Bath & Body Works, Ardent Health, and Varonis Systems for alleged securities fraud. Bath & Body Works faced significant stock declines following disappointing Q2 and Q3 2025 earnings reports, with revenue missing guidance and full-year earnings guidance slashed substantially. Investors with losses are urged to contact the firm by March 16, 2026, to potentially serve as lead plaintiff.

Shareholder class action lawsuits have been filed against Vistagen Therapeutics, Varonis Systems, and Kyndryl Holdings, alleging false and misleading statements or failure to disclose material risks. Investors who suffered losses during specified periods are encouraged to contact the law firm, with lead plaintiff deadlines ranging from March 9 to April 13, 2026.

A securities class action lawsuit has been filed against Varonis Systems, Inc. for allegedly making materially false statements regarding its ability to maintain ARR projections while converting customers to its SaaS offering. Investors who purchased stock between February 4, 2025 and October 28, 2025 may be eligible for compensation. The deadline to serve as lead plaintiff is March 9, 2026.

A class action lawsuit has been filed against Varonis Systems for allegedly making materially false and misleading statements about its business during the February-October 2025 period. The company failed to disclose that it lacked the ability to maintain its ARR growth trajectory without high quarterly conversion rates. On October 28, 2025, Varonis reported a 63.9% decline in term license subscription revenues and reduced full-year ARR guidance, causing the stock to plummet 48.7%. Investors have until March 9, 2026 to apply as lead plaintiffs.

A class action lawsuit has been filed against Varonis Systems, Inc. alleging that the company made materially false statements and failed to disclose material facts regarding its ability to convert customers to its SaaS offering, resulting in artificially inflated stock prices. Investors who purchased Varonis securities between February 4, 2025 and October 28, 2025 are encouraged to join the case, with a lead plaintiff deadline of March 9, 2026.

A securities class action lawsuit has been filed against Varonis Systems, Inc. alleging that the company made materially false and misleading statements regarding its ability to maintain ARR projections while converting customers to its SaaS offering. The lead plaintiff deadline is March 9, 2026. Investors who purchased VRNS stock between February 4, 2025 and October 28, 2025 may be eligible to join the class action.

Levi & Korsinsky has filed a class action securities lawsuit against Varonis Systems for alleged fraud between February 4, 2025 and October 28, 2025. The company allegedly made false statements about its ability to convert customers to its SaaS offering. On October 28, 2025, Varonis disclosed a significant miss on ARR guidance and announced a 5% headcount reduction, causing its stock to plummet 48.67% in a single day from $63.00 to $32.34 per share.